Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (471-480 of 549) with videos related to

Pageof 55
Sort By:
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Advances in Biological Regulation|March 27, 2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cellsJessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Cadernos De Saude Publica|April 15, 1999
[Surveillance of endemic diseases in urban areas: the interface between census tract maps and morbidity data]R A Ximenes, C M Martelli, W V Souza, et al.
Lancet (London, England)|November 23, 1996
Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infectionA L de Andrade, F Zicker, R M de Oliveira, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Cancers|March 11, 2023
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and TreatmentAnastasios Gkountakos, Filippo M Martelli, Nicola Silvestris, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Pageof 55

Showing results (471-480 of 549) with videos related to

Sort By:
Pageof 55
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Advances in Biological Regulation|March 27, 2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cellsJessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Cadernos De Saude Publica|April 15, 1999
[Surveillance of endemic diseases in urban areas: the interface between census tract maps and morbidity data]R A Ximenes, C M Martelli, W V Souza, et al.
Lancet (London, England)|November 23, 1996
Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infectionA L de Andrade, F Zicker, R M de Oliveira, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Cancers|March 11, 2023
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and TreatmentAnastasios Gkountakos, Filippo M Martelli, Nicola Silvestris, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Pageof 55